Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist. [electronic resource]
Producer: 20011219Description: 1754-9 p. digitalISSN:- 0140-6736
- Acromegaly -- drug therapy
- Adult
- Blood Glucose -- drug effects
- Cohort Studies
- Drug Administration Schedule
- Female
- Growth Hormone -- blood
- Human Growth Hormone -- analogs & derivatives
- Humans
- Insulin -- blood
- Insulin-Like Growth Factor I -- metabolism
- Male
- Middle Aged
- Receptors, Somatotropin -- antagonists & inhibitors
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.